Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1693
This examiner grants 38% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18546264 | METHODS FOR REDUCING PATHOGENIC E COLI BY SELECTIVE FEED ADDITIVE INTERVENTION | Final Rejection | DSM IP Assets B.V. |
| 18702922 | TREATMENT OF VIRUSES WITH ANTIVIRAL NUCLEOSIDES | Non-Final OA | EMORY UNIVERSITY |
| 17621369 | ANIMAL FOOD COMPOSITION | Non-Final OA | MARS, INCORPORATED |
| 17768922 | METHODS OF TREATING CANCER WITH A STING AGONIST | Final Rejection | The Board of Regents of the University of Texas System |
| 18294123 | METHOD FOR REDUCING ENDOTOXIN LEVELS IN NUCLEIC ACID PURIFICATION | Non-Final OA | MERCK PATENT GMBH |
| 17906560 | METHODS AND COMPOSITIONS FOR TREATMENT OF CORONAVIRUS INFECTION | Non-Final OA | Battelle Memorial Institute |
| 18088628 | COMPOUND, SOLID CARRIER INCLUDING THE SAME AND METHOD FOR PREPARING NUCLEIC ACID | Final Rejection | Industrial Technology Research Institute |
| 18613537 | 3'-OH RNA-CONTAINING OLIGONUCLEOTIDE DEPROTECTION | Non-Final OA | ALNYLAM PHARMACEUTICALS, INC. |
| 18556879 | SYSTEM AND METHOD FOR PRODUCING MICROCRYSTALLINE CELLULOSE | Non-Final OA | ANDRITZ OY |
| 17778297 | METHOD FOR PRODUCING CELLULOSE CARBAMATE | Final Rejection | ANDRITZ OY |
| 18007407 | NOVEL THERAPEUTIC USES OF COMPOUNDS FOR ENHANCING MITOCHONDRIAL FUNCTION AND TREATING MITOCHONDRIAL DISEASES | Final Rejection | THE CHILDREN'S HOSPITAL OF PHILADELPHIA |
| 18720268 | COMPOSITIONS FOR PREVENTING OR FOR REDUCING RISK OF DEVELOPING SECONDARY INFECTIOUS DISEASES | Non-Final OA | MEIJI CO., LTD. |
| 18300468 | PHARMACOLOGIC APPROACH FOR SUPPRESSION OF CORONAVIRUSES | Final Rejection | Temple University - of the Commonwealth System of Higher Education |
| 17790697 | ALKYLATED NUCLEOSIDES, AND COMPOSITIONS AND METHODS THEREOF FOR NUCLEIC ACID DELIVERY | Final Rejection | MICROVASCULAR THERAPEUTICS, LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy